The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer

Author(s):
Meir, H. van; Burck, I.J. du; Kam, M.L. de; Welters, M.J.P.; Burg, S.H. van der (0000-0002-6556-0354); Trimbos, J.B.M.Z. (0000-0002-8017-2376); Kroon, C.D. de; Poelgeest, M.I.E. van
Published
2017
Publication type
Article / Letter to editor
Cervical cancerSurgical therapyNeoplasm recurrenceSurvivalDisease-free survival
Date issued
2017-12-31
Language
English
Is part of
European Journal of Gynaecological Oncology (2017), Vol. 38, no. 1, p. 25-32
hdl
1887/114380
doi
10.12892/ejgo3628.2017